Squarepoint Ops LLC Ikena Oncology, Inc. Transaction History

Squarepoint Ops LLC

  • $62.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$1.24 - $1.82 $34,305 - $50,352
27,666 New
27,666 $45,000
Q2 2021

Aug 16, 2021
SELL
$13.27 - $26.0 $182,581 - $357,734
-13,759 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$25.6 - $32.0 $352,230 - $440,288
13,759 New
13,759 $389,000

Others Institutions Holding IKNA

# of Institutions
61
Shares Held
30.6M
Call Options Held
0
Put Options Held
0
View Full List

About Ikena Oncology, Inc.

IKNA Quotes by TradingView
  • Ticker IKNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,257,500
  • Market Cap $56.2M
  • Description
  • Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...
More about IKNA
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email